Icare Finland, a specilist in providing fast, easy-to-use, and reliable tools for ophthalmic diagnostics, is launching their next generation self-tonometer, the iCare HOME2.

iCare HOME2 provides unsurpassed ease of use and accuracy in monitoring real-world intraocular pressure behaviour outside of the doctor’s office and clinical hours, supporting glaucoma management. Glaucoma is a chronic, progressive disease of the optic nerve. As intraocular pressure (IOP) is the only modifiable risk factor for glaucoma progression, disease management is centred around the reduction of IOP. Therefore, comprehensive and accurate information on peak IOPs and IOP fluctuation patterns is crucial.

Most patients can utilize iCare HOME2 simply by following the advice and guidance in the instruction materials, freeing up health care professionals’ precious time. iCare HOME2’s smart light guide helps the patient in positioning the device correctly and in making the measurements effortlessly and accurately, every time. It is now easier than ever for doctors to provide glaucoma management based on real-world IOP information, from finding the optimal medication and instillation schedule, to assessing the need for and effectiveness of surgery.

iCare PATIENT2 mobile app

With the novel iCare PATIENT2 mobile app, the patients can follow their own IOP trends from an iOS or Android mobile device and send the IOP measurement results easily for healthcare professional’s review in the cloud based iCare CLINIC software. Using iCare HOME2 and PATIENT2, the patient can actively participate in the care process by providing valuable information to the healthcare professional. Patient motivation for medication compliance can improve, and knowledge of the real-time IOP levels provides daily reassurance.

• For more information, visit: iCare Home2

The European Society for Medical Oncology (ESMO), the leading professional organisation for medical oncology, has updated the Clinical Practice Guidelines for Dermatological Toxicities Related to Anticancer Agents to include the recommendation of scalp cooling for the prevention of chemotherapyinduced alopecia (CIA) as a Category IIB recommendation.

Philips has unveiled the industry’s first vendorneutral, multimodality, radiology operations command center to add secure, digital, virtual scanner access to existing imaging installs across multiple systems and sites.

Bittium, a leading specialist for secure communications, connectivity, and medical technology solutions, has released a new version of Bittium Cardiac Navigator Holter ECG Analysis Software. The new Bittium Cardiac Navigator 1.4. Software version brings improvements to the P-wave detection. This will enhance the analysis accuracy of atrial fibrillation. The new version includes also minimum and […]

Masimo has received FDA clearance of the Rad-G Pulse Oximeter, a rugged handheld device that provides clinically proven SET pulse oximetry, respiration rate from the pleth (RRp), and other vital parameters for both spot-checking and continuous monitoring. With its long-lasting rechargeable battery, robust rubber casing, light weight, and a convenient new direct-connect sensor capable of monitoring both adults and children, Rad-G makes it easier for clinicians to quickly assess patients and make informed decisions anywhere pulse oximetry or vital signs checking is needed. Providing the ultimate in handheld versatility, Rad-G can be used in a variety of settings, including but not limited to physicians’ offices, outpatient services, long-term care facilities, wellness clinics, first-response scenarios, and limited-resource environments.
Launching alongside the device, the new multipurpose, direct-connect Rad-G Sensor is indicated for monitoring both adult and paediatric patients. By eliminating the need to stock and carry multiple sensor types, the Rad-G Sensor further increases Rad-G’s versatility and ease of use, especially in more challenging field environments. In addition to this innovative new sensor, Rad-G is compatible with the vast portfolio of Masimo reusable and single-patient-use sensors, maximizing its flexibility and offering clinicians the ability to customize the solution based on the unique needs of each care setting.
The high-resolution screen displays a continuous pleth waveform and its fully configurable, audible alarms help alert clinicians to changes in patient status that may require their intervention.
In addition to Masimo SET oxygen saturation (SpO2), pulse rate (PR), perfusion index (Pi), and pleth variability index (PVi), Rad-G is also notable for its ability to use the same sensor to monitor respiration rate from the plethysmograph, with RRp. SpO2 and PR monitoring on Rad-G is provided using clinically proven Masimo SET Measure-through Motion and Low Perfusion pulse oximetry.
For more information, visit: www.masimo.com
Read more